Progressive changes in cardiac critical care have driven a need for innovation in research and clinical care. The Critical Care Cardiology Trials Network (CCCTN) is a collaborative research network drawn from national leaders in critical care cardiology and coordinated by the TIMI Study Group. Our mission is to design and execute observational studies and clinical trials that will advance the care of patients who require cardiac critical care.
Learn about the CCCTN COVID-PACT clinical trial, a multicenter, randomized, open-label, 2 x 2 factorial design trial of full-dose anticoagulation vs. standard-dose prophylactic anticoagulation and antiplatelet therapy vs. no antiplatelet therapy on the risk of venous or arterial thrombotic events in ICU patients with COVID-19. Study patients will be followed until their 28th day or hospital discharge, whichever comes first.
Temporary Mechanical Circulatory Support Use In Tertiary Cardiac Intensive Care Units Before And After The UNOS Heart Transplantation Allocation System Update: Insights From The Critical Care Cardiology Trials Network (CCCTN) Registry (Varshney ACC 2020)
Incidence, underlying conditions, and outcomes of patients receiving acute renal replacement therapies in tertiary cardiac intensive care units: An analysis from the Critical Care Cardiology Trials Network Registry
Demographics, Care Patterns, and Outcomes of Patients Admitted to Cardiac Intensive Care Units: The Critical Care Cardiology Trials Network Prospective North American Multicenter Registry of Cardiac Critical Illness